Bernice Z. Yu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bernice Z. Yu has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Jacquelyn Roth
Icahn School of Medicine at Mount Sinai
4 shared publications - Peter William Henderson
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, 10 Union Square East, Suite 2 L, New York, NY 10003, United States
4 shared publications - Ethan Fung
Division of Plastic and Reconstructive Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3 shared publications - Keisha E. Montalmant
Division of Plastic and Reconstructive Surgery, Department of Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA
3 shared publications Jacquelyn M. Roth
Division of Plastic and Maxillofacial Surgery, Icahn School of Medicine at Mount Sinai
2 shared publications- Matthew Q. Dao
John Sealy School of Medicine, University of Texas Medical Branch, Galveston, TX 77555, USA
2 shared publications
Latest Publications
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 573-581
Serotonergic Antidepressant Use After Recent Facial Burn Injury is Associated with Hypertrophic Scarring, Metabolic Complications, and Reduced Mortality
Facial burns can cause profound psychological distress, often treated with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. While their psychiatric benefits are established, their impact on wound healing and long-term outcomes is less defined. This study examines associations between early serotonergic antidepressant exposure and physiological complications following facial burn injury. Adult patients with second- or third-degree facial burns (2010-2025) were identified in the TriNetX US Collaborative Network. Those prescribed antidepressants within one month of injury were compared to controls without antidepressant use. Propensity score–matching was performed based on demographics, burn characteristics, and psychiatric as well as medical comorbidities. Outcomes assessed at 90 days, 180 days, and 1 year included skin infection, hypertrophic scarring, lactic acidosis, hyperglycemia, hypoglycemia, and mortality. Univariate regression analyses were used to compare each outcome, with significance defined as P < .05. Of 46 971 facial burn patients identified, 3392 remained in each group after matching. Patients in the matched antidepressant group had significantly higher rates of hypertrophic scarring and skin infection at all time points compared to those in the matched control group (P < .01). Additionally, lactic acidosis and hyperglycemia became elevated beginning at 180 days (P < .05) among patients who were prescribed antidepressants. Mortality, however, was consistently lower in the matched antidepressant group at all time intervals (P < .05). Early serotonergic antidepressant use after facial burn injury is linked to increased risk of hypertrophic scar formation, infection, and metabolic disturbances, yet decreased rates of mortality.
- 9 October 2025
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 47 (2) , 573-581
Serotonergic Antidepressant Use After Recent Facial Burn Injury is Associated with Hypertrophic Scarring, Metabolic Complications, and Reduced Mortality
Facial burns can cause profound psychological distress, often treated with selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors. While their psychiatric benefits are established, their impact on wound healing and long-term outcomes is less defined. This study examines associations between early serotonergic antidepressant exposure and physiological complications following facial burn injury. Adult patients with second- or third-degree facial burns (2010-2025) were identified in the TriNetX US Collaborative Network. Those prescribed antidepressants within one month of injury were compared to controls without antidepressant use. Propensity score–matching was performed based on demographics, burn characteristics, and psychiatric as well as medical comorbidities. Outcomes assessed at 90 days, 180 days, and 1 year included skin infection, hypertrophic scarring, lactic acidosis, hyperglycemia, hypoglycemia, and mortality. Univariate regression analyses were used to compare each outcome, with significance defined as P < .05. Of 46 971 facial burn patients identified, 3392 remained in each group after matching. Patients in the matched antidepressant group had significantly higher rates of hypertrophic scarring and skin infection at all time points compared to those in the matched control group (P < .01). Additionally, lactic acidosis and hyperglycemia became elevated beginning at 180 days (P < .05) among patients who were prescribed antidepressants. Mortality, however, was consistently lower in the matched antidepressant group at all time intervals (P < .05). Early serotonergic antidepressant use after facial burn injury is linked to increased risk of hypertrophic scar formation, infection, and metabolic disturbances, yet decreased rates of mortality.
- 25 July 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (1/2) , 225-232
Orthognathic Surgery: Anesthetic Considerations and Perioperative Management
Orthognathic surgery presents a unique perioperative landscape for plastic surgeons and anesthesiologists alike including blood loss and pain control, as well as postoperative complications such as shivering, nausea and vomiting, emergence agitation, and prolonged ventilation. Blood loss is a major concern due to the inherent rich vascularity of the facial skeleton and significant muscular and bone marrow dissection. Effective hemostatic strategies are critical in preventing excessive blood loss, with the 2 primary strategies being judicial hypotensive anesthesia and use of hemostatic agents. Pain control is a consideration throughout all surgical phases with preoperative nerve blocks, anesthetic agents for induction and maintenance of anesthesia, and postoperative analgesia. Preoperative nerve blocks, regardless of technique either a single injection at the pterygopalatine fossa or ultrasound guided, have demonstrated increased hemodynamic stability and decreased need for postoperative opioid use. While nausea, vomiting, shivering, emergence agitation, and prolonged ventilation can be observed in other procedures, these postoperative complications need additional consideration in the setting of orthognathic surgery. Maxillomandibular fixation increases the risk of aspiration in the presence of nausea and vomiting, while delayed extubation, emergence agitation and shivering can contribute to airway disturbance and other complications. Given the cross-specialty complexity in these procedures, the present paper sought to provide a comprehensive review of the evidence-based literature on perioperative anesthetic practices with a focus on hypotensive anesthesia, hemostasis, nerve blocks, and management of postoperative complications.
- 25 July 2025
- Published by Wolters Kluwer Health in Journal of Craniofacial Surgery
- Vol. 37 (1/2) , 225-232
Orthognathic Surgery: Anesthetic Considerations and Perioperative Management
Orthognathic surgery presents a unique perioperative landscape for plastic surgeons and anesthesiologists alike including blood loss and pain control, as well as postoperative complications such as shivering, nausea and vomiting, emergence agitation, and prolonged ventilation. Blood loss is a major concern due to the inherent rich vascularity of the facial skeleton and significant muscular and bone marrow dissection. Effective hemostatic strategies are critical in preventing excessive blood loss, with the 2 primary strategies being judicial hypotensive anesthesia and use of hemostatic agents. Pain control is a consideration throughout all surgical phases with preoperative nerve blocks, anesthetic agents for induction and maintenance of anesthesia, and postoperative analgesia. Preoperative nerve blocks, regardless of technique either a single injection at the pterygopalatine fossa or ultrasound guided, have demonstrated increased hemodynamic stability and decreased need for postoperative opioid use. While nausea, vomiting, shivering, emergence agitation, and prolonged ventilation can be observed in other procedures, these postoperative complications need additional consideration in the setting of orthognathic surgery. Maxillomandibular fixation increases the risk of aspiration in the presence of nausea and vomiting, while delayed extubation, emergence agitation and shivering can contribute to airway disturbance and other complications. Given the cross-specialty complexity in these procedures, the present paper sought to provide a comprehensive review of the evidence-based literature on perioperative anesthetic practices with a focus on hypotensive anesthesia, hemostasis, nerve blocks, and management of postoperative complications.
- 15 May 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 213-220
Social support holds protective value in breast reconstruction
- 15 May 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 106, 213-220
Social support holds protective value in breast reconstruction
- 12 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 259-272
The current state of tranexamic acid in mastectomy and breast reconstruction: A systematic review and meta-analysis
- 12 March 2025
- Published by Elsevier in Journal of Plastic, Reconstructive & Aesthetic Surgery
- Vol. 104, 259-272
The current state of tranexamic acid in mastectomy and breast reconstruction: A systematic review and meta-analysis
- Open Access
- 1 January 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (1) , 105-107
Preliminary results from randomized control trial point toward the utility of neurotization in innervated breast reconstruction
Preliminary results from randomized control trial point toward the utility of neurotization in innervated breast reconstruction
- 1 January 2025
- Published by AME Publishing Company in Gland Surgery
- Vol. 14 (1) , 105-107
Open AccessPreliminary results from randomized control trial point toward the utility of neurotization in innervated breast reconstruction
Preliminary results from randomized control trial point toward the utility of neurotization in innervated breast reconstruction